Cash & equivalents increased 44.7%
Cash & equivalents changed +44.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +44.7% from the comparable as-filed period.
Net income changed +36.6% from the comparable as-filed period.
Operating income changed +44.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +2849 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed +34.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Stock-based compensation changed -21.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Selling, general & administrative changed +8.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Debt changed -0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
Research & development changed -4.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.